HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Sign In to gain access to subscriptions and/or personal tools.

This Article Full Text Full Text (PDF) All Versions of this Article: 0091270008318669v1 48/8/986    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Request Reprints Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hilli, J. Articles by Laine, K. Search for Related Content PubMed PubMed Citation Articles by Hilli, J. Articles by Laine, K. Social Bookmarking                         What's this?

The Effect of Oral Contraceptives on the Pharmacokinetics of Melatonin in Healthy Subjects With CYP1A2 g.-163C>A Polymorphism

From the Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku, Finland and Clinical Pharmacology, TYKSLAB, Health Care District of Southwest Finland (Dr Hilli, Dr Laine); SFINX Drug Interaction Unit, Turku University Hospital, Turku, Finland (Dr Korhonen); Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland and Novamass Analytical Ltd, Oulu, Finland (Dr Turpeinen); and Department of Chemistry, University of Oulu, Oulu, Finland (Mr Hokkanen, Dr Mattila).

The effect of oral contraceptives (OCs) on melatonin metabolism was studied in 29 subjects genotyped for CYP1A2 SNP g.-163C>A polymorphism. Plasma melatonin and 6-OH-melatonin concentrations were measured after a 6-mg dose of melatonin using a validated liquid chromatography/mass spectrometry method. The mean melatonin AUC and C_max values were 4- to 5-fold higher in OC users than in non-OC users (P < .0001), whereas the weight-adjusted clearance was significantly lower in OC users (P < .0001). No significant difference in melatonin pharmacokinetics between the genotypes and no additional effect by the genotype on the OC-induced increase in melatonin exposure were evident. Melatonin exposure had no significant effect on the subjects' state of alertness. In conclusion, a significant inhibitory effect of OCs on the CYP1A2-catalyzed melatonin metabolism was seen; thereby, OC use can alter CYP1A2-phenotyping results.

Key Words: YP1A2 polymorphism • SNP g.-163C>A • melatonin • oral contraceptives • ethinylestradiol

Address for reprints: Johanna Hilli, MD, PhD, Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Itäinen Pitkäkatu 4B, 3rd Floor, FIN-20520 Turku, Finland; e-mail: johanna.hilli{at}utu.fi.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S.-Y. Chang, C. Chen, Z. Yang, and A. D. Rodrigues Further Assessment of 17{alpha}-Ethinyl Estradiol as an Inhibitor of Different Human Cytochrome P450 Forms in Vitro Drug Metab. Dispos., August 1, 2009; 37(8): 1667 - 1675. [Abstract] [Full Text] [PDF]